C12Y 101/01046
L-arabinose 1-dehydrogenase
Official title: L-Arabinose 1-dehydrogenase (1.1.1.46)
C12Y101/01046 (L-arabinose 1-dehydrogenase) appears on 3 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 6
- Assignees
- 3
- Inventors
- 12
- Latest grant
- 23 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 1 |
| 2020 | 1 | 1 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
By publication year.
Recent patents
- Increased biosynthesis of benzylisoquinoline alkaloids and benzylisoquinoline alkaloid precursors in a recombinant host cell23 Apr 2024US 11,965,181 B2River Stone Biotech, LLC
- Increased biosynthesis of benzylisoquinoline alkaloids and benzylisoquinoline alkaloid precursors in a recombinant host cell13 Jul 2021US 11,060,071 B2River Stone Biotech, LLC
- Method for obtaining sugar derivatives18 Feb 2020US 10,563,237 B2Annikki GmbH
- Biosynthesis of benzylisoquinoline alkaloids and benzylisoquinoline alkaloid precursors4 Nov 2021US 2021/0340505 A1River Stone Biotech, LLC
- Process for enzymatic production of oxidation and reduction products of mixed sugars30 Jul 2020US 2020/0239918 A1Annikki GmbH
- Biosynthesis of benzylisoquinoline alkaloids and benzylisoquinoline alkaloid precursors7 Nov 2019US 2019/0338255 A1River Stone Biotech, LLC
- Process for enzymatic production of oxidation and reduction products of mixed sugars2 Aug 2018US 2018/0216142 A1Annikki GmbH
- Recombinant cells and methods for nonphosphorylative metabolism18 May 2017US 2017/0137855 A1Regents of the University of Minnesota
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.